Item 5. Market for Registrant’s Common Equity
Item
5. Market For Registrant’s Common Equity, Related Shareholder Matters And Issuer Purchases Of Equity Securities
(a) Market
Information
Our
Units began trading on Nasdaq under the symbol “OIMAU” on January 14, 2026. Holders of our Units may elect to separately
trade the Class A ordinary shares and warrants included in the Units commencing on March 6, 2026 on Nasdaq under the symbols “OIM”
and “OIMAW,” respectively. Those Units not separated will continue to trade on the Nasdaq under the symbol “OIMAU”
and each of the Class A ordinary shares and warrants that are separated will trade on Nasdaq under the symbols “OIM” and
“OIMAW,” respectively. Each whole warrant entitles the holder to purchase of one share of Class A ordinary shares at a price
of $11.50 per share. Warrants may only be exercised for a whole number of shares of Class A ordinary shares and will become exercisable
on the later of 30 days after the completion of our initial business combination or 12 months from the IPO Closing Date. Our warrants
expire five years after the completion of our business combination or earlier upon redemption or liquidation as described in “Item
1. Business.”
(b) Holders
As of March 24, 2026, there
were 2 holders of record of our Units, 2 holders of record of our Class A Ordinary Shares, 1 holder of record of our Warrants and 3 holders of record of our Founder Shares.
(c) Dividends
We
have not paid any cash dividends on our Class A ordinary shares or Founder Shares to date and do not intend to pay cash dividends in
the foreseeable future. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital
requirements and general financial condition subsequent to completion of our initial business combination. The payment of any cash dividends
subsequent to our business combination will be within the discretion of our board of directors at such time. In addition, our board of
directors is not currently contemplating and does not anticipate declaring any stock dividends in the foreseeable future. Further, if
we incur any indebtedness in connection with our initial business combination, our ability to declare dividends may be limited by restrictive
covenants we may agree to in connection therewith.
(d) Securities
Authorized for Issuance Under Equity Compensation Plans
None.
(e) Recent
Sales of Unregistered Securities; Use of Proceeds from Registered Offerings
Unregistered
Sales
On
September 11, 2025, the Sponsor purchased 7,187,500 Founder Shares of the Company for $25,000, or approximately $0.003 per share.
On
January 9, 2026, the Sponsor entered into entered into a securities transfer agreements, pursuant to which the Sponsor transferred and
aggregate of 50,000 Founder Shares to each of the independent directors at their original purchase price. The issuance of such Class
B ordinary shares to the Sponsor was made pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act.
On
January 15, 2026 we consummated the IPO of 28,750,000 Units at $10.00 per Unit, which includes the full exercise by the underwriters
of their over-allotment option in the amount of 3,750,000 Units, generating gross proceeds of $287,500,000. The securities in the offering
were registered under the Securities Act on a registration statement on Form S-1 (File No. 333-292356). The Securities and Exchange Commission
declared the registration statement effective on January 13, 2026.
61
Simultaneously with the closing
of the IPO, we consummated the sale of an aggregate of 200,000 Private Placement Units at a price of $10.00 per Private Placement Unit,
in a private placement to the Sponsor, generating gross proceeds of $2,000,000.
Of the gross proceeds received
from the IPO, the exercise of the over-allotment option and the Private Placement Units, an aggregate of $287,500,000 was placed in the
Trust Account.
Use
of Proceeds
On
January 13, 2026, our registration statement on Form S-1 (File No. 333-292356) was declared effective by the SEC for the IPO pursuant
to which we sold an aggregate of 28,750,000 Units at an offering price to the public of $10.00 per Unit, generating gross proceeds of
$287,500,000.
Item
6. [Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.